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INTRODUCTION 
Patients   with suspected Acute coronary syndrome in the setting of 
presumably new onset LBBB is a  diagnostic puzzle and the decision  to 
initiate reperfusion therapy  has to be taken with utmost caution. The logic 
behind  using ST elevation as criteria for reperfusion therapy was for its 
specificity in picking up the patients with total occlusion of coronary 
artery and identifying  the  most probable candidates likely to gain from 
reperfusion. 
 In this regard new onset LBBB was also considered as STEMI 
equivalent.But the difficulty  in  LBBB  is that during repolarization there 
is a deviation of ST segment away from the QRS complex.As a 
consequence the ECG manifestation of ST segment elevation in STEMI 
could be  masked or mimicked by the secondary ST  segment deviation of 
LBBB.Based on this diagnostic uncertainity there was recommendation in 
1996 and 2004  American college of cardiology [ACC] and American 
heart Association [AHA] to consider new onset LBBB as Class Ia 
indication for emergent reperfusion therapy.These recommendation were 
based on the Fibrinolytic Therapist Review on several randomized control 
trials during the fibrinolytic era 
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But Later studies using angiography concluded there is no 
documented   coronary occlusion angiographically in majority of the 
people with new onset LBBB.Now there is a paradigm shift in the 
management of the patient with new onset LBBB and the new 2013 
STEMI guidelines  byAmerican College of cardiology and American 
Heart Association has removed the previous recommendations that the 
new onset LBBB should be treated as STEMI equivalents 
           My studyis to find  the  incidence of Acute Myocardial Infarction 
in patients with potential ischemic symptoms  in relation to the presence 
of old  or  new onset LBBB and to analyze whether  new onset LBBB 
predicts increased likelihood of Acute MI by monitoring with  serial 
Troponin T and echocardiography. 
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Aim 
To study the relevance of LBBB as diagnostic criteria for Acute 
myocardial Infarction 
 
Objectives 
To study  the  incidence of Acute Myocardial Infarction in patients 
with potential ischemic symptoms  in relation to the presence of old  or  
new onset LBBB 
To analyze whether  new onset LBBB predicts increased likelihood 
of Acute MI 
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REVIEW OF LITERATURE 
 Myocardial Infarction is one of the most challenging clinical 
conditions in cardiology but also the most gratifying when treated 
promptly and appropriately. Recent advances in the management of MI 
have shown the prompt treatment can save lives and restore normal 
cardiac function.. Delay or sub optimal management at any stage can 
affect outcomes. 
The National Commission on Macro-economics and Health has 
estimated the   evolving epidemic of CAHD  in India - 60 million 
patients  by the year 2015 with an  annual  mortality    three  million. A 
good  number of this will be caused due to acute Myocardial Infarction  
or its  delayed consequences. Even though   Europe and United states  
have substantially fewer STEMI, the national bodies have formulated 
appropriate guidelines and there are audits and attempts to encourage 
and monitor adherence. Unfortunately there is no national guideline or 
policy in India 
         Rapid and prompt diagnosis of MI is extremely important  in 
initiating reperfusion therapy . For most of the patients presenting to 
emergency department with chest pain, ECG still is the first foremost 
and most important diagnostic tool in identifying the patient for 
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reperfusion therapy. However patients presenting with concomitant left 
bundle branch the electrical manifestation of  Myocardial Infarction 
may be masked. 
 Left bundle branch block presents a dilemma for many clinicians 
in the evaluation of chest pain (or other signs and symptoms of ACS). 
 There is a pervasive myth that it’s impossible to diagnose acute 
STEMI in the presence of left bundle branch block 
 Left bundle branch block causes a secondary ST/T-wave 
abnormality that makes the diagnosis of acute STEMI more 
difficult 
 “New” left bundle branch block was long considered to be a 
STEMI equivalent (many still believe this to be the case) 
 Historically there has been a high rate of “false positive” cardiac 
cath lab activations based on the presence of left bundle branch 
block 
 The diagnostic criteria to identify acute myocardial infarction in 
the presence of left bundle branch block (Sgarbossa’s criteria) 
was originally based on a rise and fall of cardiac biomarkers, not 
angiography (in other words it combined STEMI and NSTEMI) 
18 
 
 For these reasons, when it comes to field activation of the cardiac 
cath lab, most EMS protocols exclude patients with left bundle branch 
block or paced rhythm. 
“It is impossible to  diagnose STEMI in the presence of left bundle 
branch block” 
The myth is well rooted in the medical literature.  
“It is well recognized that the electrocardiographic diagnosis of 
myocardial infarction in the presence of complete left bundle branch 
block is in most instances difficult and frequently impossible.” Int J 
Cardiol. 1983;2(5-6):521-9 
“It is common knowledge that the ECG diagnosis of completed 
myocardial infarction in the presence of left bundle branch block 
(LBBB) is extremely difficult and often impossible.” – Ann Emerg 
Med. 1995 Jul;26(1)69-82 
This was considered to be a STEMI equivalent as recently as the 2010 
AHA ECC Guidelines! And 2012 European guidelines 
. “The 2010 ACC/AHA STEMI guidelines recommended emergent 
reperfusion therapy including fibrinolytics or primary percutaneous 
coronary intervention (PCI) in patients with symptoms compatible with 
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STEMI and new or presumably new LBBB if these symptoms arose in 
the prior 12 hours (Class I Indication)” 
 “The 2012 European Society of Cardiology STEMI guidelines 
also recommend early PCI or fibrinolytics in patients with a clinical 
presentation of STEMI and new or presumably new LBBB if symptoms 
arose in the prior 12 hours (Class Ia Indication)” 
 The 2013 ACC/AHA STEMI guidelines changed previous 
recommendations for patients with suspected ischemia and new or 
presumably new LBBB should not be treated as a STEMI equivalent 
 
 The purpose of our study was to determine the prevalence of 
AMI in patients who present with chest pain or an ischemic equivalent 
and have a new or presumed new LBBB. 
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NORMAL CARDIAC CELLULAR AND ELECTRICAL 
ACTIVITY  
 The excitability of the cells is due to the basic and well known 
cellular action potential.All normal cariac cells have a resting diastolic 
transmembrane potential  of approximately -60 mv [SA nodal cells] to -
90 mv [contractile cells]that is established by sodium potassium ATPase  
pump during phase 4 of the action potential. 
This pump generates an electrolyte gradient  with high potassium 
inside the cells and high sodium concentration outside of the cells.The 
charge on the membrane depends upon which of the two ions can freely 
cross the membrane.In diastole the cell is more permeable to K+ which 
provides for the nagative member potential. 
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Fig 1 : Electric Potential of the cell 
 Automacity is generated in the non contractile pacemaker cells of 
the heart because of slowly depolarizing NA+ leak into cell during 
phase 4.The stable phase 4 diastolic  transmembrane potential in 
contractile cells explains their lack of automacity and is what allows for 
their stable diastolic polarization.This is what produces the cellular 
polarity  that is the foundation for the electrical vectors that ultimately 
forms the familiar QRS-T pattern on the ECG.When the membrane 
potential crosses a hreshold whether it is due to phase 4 leak or direct 
stimulus fast Na+ channels open and phase 0 depolarisationoccurs.The 
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transmembrane   potential overshoots initially in phase 1 depolarisation 
reaching around +20 mv and then plateaus at 0mv during phase 2.This 
plateau is achieved by slow calcium influx  balancing the slow  K+ 
efflux and allows for prolonged contraction in cardiac myocytes.During 
phase 3 repolarisation calcium channels close and K+ efflux restores the 
negative resting membrane potential 
 After the initial stimulus on the cell the membrane doesn’t 
completely and instantaneously depolarize through out the length of the 
cell. Rather it is a process that begins at the point of origin  and 
continues  three dimensionally towards the other pole of the cell.At rest 
the K+ permeability gives the cell membrane a negative potential which 
is analogous to having a positive charge on the outside of the cell.The 
cell membrane then becomes negative  after depolarization.As 
depolarization progresses  a dipole is setup with the vector oriented 
from the negative to positive portion of the cell.  
A single positive electrode on the resting  side of the cell would 
show a positive electrode deflection which would be greatest when the 
cell is halfway depolarized.In normal cells subsequent repolarization 
starts at the same location where depolarization began and progreses 
from the newly repolarized positive side to the still depolarized portion 
that is negative.  
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On a cellular level in contrast to clinical ECG the direction of the 
repolarization vector is oriented exactly opposite to depolarization 
vector.Myocardial cells contract when depolarized and their 
depolarization depolarizes succeeding cells leading to conductivity. 
    On an organ level the depolarization of the heart is represented 
electrocardiographically by the QRS and has a similar upright pattern as 
compared with cellular depolarization. Cardiac repolarization  however 
is the opposite of cellular depolarization with a vector [T wave] that is 
normally positive.This is due to repolarization delay in the 
subendocardium resulting in a repolarizing  wave  moving away from 
the positive electrode  and progressing from the subepicardium to the 
subendocardium.This delay is hypothesized to be due to a chronic 
hypometabolic state in the subendocardium secondary to poor blood 
supply which behaves electrically like ischemic tissue.The result is 
familiar upright QRS T pattern of the ECG. 
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    ANATOMIC CORELATES OF ECG 
 
Standard lead placement is essential for accurate measurement of ECG. 
 
  
Fig 2 : Lead Placement on the Chest 
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One can relate the area of myocardium involved and coronary artery 
circulation affected with ECG changes. 
 
Fig 3 : coronary Anatomy 
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Fig 4 : Leads on the Heart 
 
1. Inferior wall MI is identified by changes in lead III. Inferior wall 
MI often shows a ST elevation   in lead  III and ST depression in 
lead aVL unless there is concurrent lateral wall injury. 
2. Lead aVL  is best for detecting high lateral wall MI. Lateral wall 
MI is also detected in leads I and V5 V6 
3. Septal MI is detected by changes in lead V1 
4. Anterior wll MI causes ST elevation in V2 – V4 
5. RV AMI causes ST elevation in V1. Right sided ECG shows 
reversal of V1 and V2. 
6.  Posterior wall AMI manifests as ST depression in V1 – V3 
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TABLE 1. ST ELEVATION, LOCATION OF STEMI, AND 
CORRESPONDING CORONARY ARTERY 
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Ischemic processes 
 A cascade of events occurs in ischemic cells beginning with 
metabolic changes and subsequent electrical changes and alterations in 
contractility. Intracellular K+ decreases because of the decreased 
activity of the NA+/K+ ATPase  pump. This causes a decrease in 
diastolic transmembrane potential and results in delayed phase 3 
repolarization. Additionally in ischemic cells repolarization  originates 
at the last point in the cell membrane to depolarize unlike a normal cell 
in which repolarization begins at the same point that depolarization 
began. Therefore in ischemia the cellular repolarization vector will be 
opposite to that of a normal cell and will be delayed. 
Hyperacute T waves and T waves inversion 
 Subendocardial ischemia is the first pathologic process to have an 
ECG correlate during acute coronary syndrome. Endocardial ischemia 
results in delayed recoverey of this area.Since repolarization normally 
proceeds from the epicardium to the endocardium the direction of the 
repolarization vector does not change but the amplitude of the vector 
increases resulting in a hyperacute T wave.Subepicardial ischemia 
results in delay subepicardial repolarization and a reverse in direction of 
the repolarization vector;the result in this situation is T wave 
inversion.Subepicardial ischemia rarely occurs without involvement of 
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the endocardium[transmural ischemia].However the ECG picture is 
dominated by subepicardial ischemia.This is due most likely to the 
closer proximity of the epicardium to the electrode as well as to the 
relative mass of the subepicardium as compared with the 
endocardium.On the standard 12 lead ECG this pattern holds true for 
inferior ,lateral and anteroor ischemia whereas the reverse is true for 
posterior wall ischemia.In the anterior leads [V1 - V2] posterior 
subepicardial ischemia causes  a positive T wave, whereas  
subendocardial  ischemia results in a more negative T wave 
ST segment Changes Two theories 
 The current of injury theory explains the ST segment changes 
during myocardial injury.Damaged cells lose their membrane integrity 
resilting in K+ leak. The outside of cell becomes more electrically 
negative which decreases the charge of the baseline or isoelectric line. 
If the damage is near positive electrode as in subepicardial/transmural 
injury the baseline TP segment decrease in voltage and the ST segment 
is then elevated relative to this base line. Since the cells still depolarize 
the ST segment remains at  normal isoelectric line .In subendocardial 
injury the tissue becomes more negative at a distance from the electrode 
causing  electrode resulting in a more positive vector for the isoelectric 
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line .In this situation the isoelectric line increases and the ST segment 
appears depressed. 
 The incomplete depolarization theory is based on the belief that 
damaged cells donot completely depolarize.If the electrode is in close 
proximity to damaged cells as in subepicardial/transmural injury a more 
positive ST segment will be maintained during systole.The partial 
depolarization of subendocardial injury would result in ST depression 
in leads over the normally depolarizing epicardium.With this theory 
there is no change to iso electric line. 
Reciprocal changes  
 When the transmural injury occurs in addition to ST segment 
elevations at proximate electrodes, distant electrodes may show ST 
depression .These reciprocal changes of transmural injury can be 
explained by the preceding theories.There must be ST elevation at some 
recording electrode for ST depressions to be called reciprocal changes 
rather than simply subendocardial injury. 
Q Waves 
 QRS changes in the first 40 ms of depolarization can be due 
either to preexcitation or infarction.Usually the degree of infarction 
necessary to result in pathologic Q waves is only seen in transmural 
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infarctions.Normal ventricular depolarization begins in the septum for 
the initial 20 ms.proceed to anterior inferior and lateral walls over the 
next 30 to 40 ms and terminates in posterior and high lateral walls.In 
the case of infarction the dead tissue becomes electrically silent.The 
vector for the initial 40 ms points away from the quiet tissue towards 
normal muscle resulting in classic ECG changes.In inferior and lateral 
infarcts the result is ep pathologic Q waves.Anterior septal infarcts will 
lose thweir R wave progression across the precordium and the loss of 
initial septal Q waves in Leads I,Avl,v5,v6.Anterior wall infarcts results 
in forces deviated to the right with an R wave in v1,while maintaining 
normal septal Q waves in leads I,Avl,v5,v6. 
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ANTERIOR WALL MI 
Fig 4  : Blood supply of the anterior wall of the heart. 
 Left main coronary artery supplies left anterior descending  and 
circumflex arteries. 
 Proximal LAD occlusion causes lateral AMI , anteroseptal AMI 
or antero septal lateral AMI while mid LAD occlusion causes AMI. 
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ECG CHANGES IN ANTERIOR AMI 
Fig 5 : ECG CHANGES IN ANTERIOR AMI 
ST ELEVATION changes are seen in 
1. Anterior AMI -V2- V4  
2. Anterolateral AMI- changes are noted in V1- V4, V5 V6 and/or I 
and aVL 
3. Anteroseptal AMI- elevation noted in V1- V4. Whenever ST 
elevation is seen in aVR it is indicative of occlusion proximal to 1st 
septal perforator. 
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4. Anteroinferior wall AMI  manifests as ST elevation in V2- V4 and 
in II III and aVF. 
PSUEDO ANTEROSEPTAL AMI 
 Pseudo anteroseptal AMI is one that looks like anterior AMI but 
is actually large high risk right ventricular AMI due to occlusion of 
proximal right coronary artery.  
It manifests as 
1. ST elevation in V1 – V3 (+_V4 V5) 
2. Development of Q waves in V1-V3 
3. Occurs with concomitant inferior AMI usually recognised by ST 
elevations in II III and aVF. 
 
INFERIOR ST DEPRESSION CHANGES NOTED IN 
ANTERIOR MI 
1. ST depression > 1mm in lead II is predictive of occlusion proximal 
to the first diagonal artery 
2. ST depression in lead III  ST elevation in aVL  
3.  Presence of reciprocal changes is associated with higher precordial 
elevation and often carries a poor prognosis. 
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ANTERIOR WALL AMI LOOK ALIKES 
  It often mimics early repolarisation , LVH, ventricular 
aneurysms and occasionally pericaditis. 
PREDICTORS OF MORTALITY IN AMI 
 Overall mortality of patients treated with thrombolytics is 9.9%. 
the predictors of greater mortality are 
1. Greater number of leads with ST elevation 
2. Greater height of ST segments 
3. Presence of reciprocal ST depression 
4. Sum of absolute ST segment variations greater than 1.2 mv 
5. Terminal QRS distortion by ST segment. 
 These factors are also indicative of increased benefits of 
reperfusion therapy. 
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LEFT BUNDLE – BRANCH BLOCK 
Fig 6 : Left Bundle – Branch Block 
 LBBB is a conduction abnormality in which specialized 
conducting fibers of the left bundle are non functional resulting in 
electrical propogation through slow conducting myocardium. 
 LBBB may be due to many disease states including 
cardiomyopathy and AMI.Unlike RBBB, LBBB with or without AMI 
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typically manifests ST elevation in the absence of any ischemia or 
infarction.Consequently the specificity of ST elevation for AMI when 
there is concurrent LBBB is much less than when there is normal 
conduction. 
LBBB  
 
Fig 7 : ECG of Left Bundle – Branch Block 
ECG diagnosis of LBBB 
 In LBBB with or without AMI the leftward component of the 
ECG complex is wide due to the propogation of depolarization through 
slow conducting myocardium. 
Criteria for Diagnosis of LBBB 
 The following are criteria that must be present for the diagnosis 
of LBBBB. 
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Fig 8 : Wide QRS complex 
QRS > 120 ms 
Lead I wide monophasic R wave 
Any Q wave in Leads I,avl,V5 or V6 due to presence of MI,not result of 
old LBBB 
Delayed intrinsicoid deflection in leads 
 V5-V6[>O.O4 sec to peak of R] 
Fig 8 : W Pattern & M Pattern 
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The following features are typicaly present 
V1; QS or RS pattern with large ,deep s wave 
 
Fig 9 : Changes in V1 
Left axis deviation 
 Discordant ST deviation and T wave inversion. Uncomplicated 
LBBB almost always manifest  ST deviation and discordant T waves 
which means that ST segment and T waves are in direction opposite to 
the predominance of QRS complex.The magnitude of discordance 
should be proportional to the voltage of the QR.When discordance is 
not present ischemia or infarction should be suspected 
LBBB Variations 
 Incomplete LBBB manifest a QRS duration of 100 to 120 ms 
other criteria are identical to those listed for LBBB 
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Rate limited LBBB may occur if the heart rate is too fast usually  
>100 beats per minute to allow repolarization of an abnormal 
conduction system with a prolonged refractory period .In these cases 
BBB may resolve with slowing of heart rate ,thus making ECG 
diagnosis easier 
     Intraventricular conduction delay is a term used to describe a 
wide QRS complex [100 ms or more] that occurs with no specific 
morphology 
LBBB WITH AMI 
Clinical factors 
 The prevalence of AMI in patients with ischemic symptoms and 
LBBB depends on the clinical situation. 
 LBBB is associated with chronic ischemic and non ischemic 
cardiomyopathy as wellas with AMI.A history of congestive cardiac 
failure ,dilated cardiomyopathy ,low ejection fraction or a chest film 
revealing cardiomegaly provides evidence that the LBBB is not new 
.Because LBBB may be present in many patients with nonischemic 
CHF,if the LBBB in not known to be new and there are no specific 
ECG findings of AMI ,it is important to ensure that the patient is 
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experiencing typical and ongoing symptoms before administering 
thrombolytics. 
 LBBB occurs in 6.7% of all AMI as diagnosed by CK MB.LBBB 
detected during continuous monitoring for 36 to 72 hours after 
thrombolytics  may appear atleast transiently in upto 10.5% of AMI 
patients.Compared with patients with AMI and neither RBBB or LBBB 
patients  with AMI and LBBB are older , more likely to present without 
chest pain.As diagnosed by CKMB only 8.4% to 16.6% of patients with 
LBBB and AMI receive any reperfusion therapy,most commonly 
because of non diagnostic ECG.This is in contrast to 32% of patients 
with AMI and no BBB who receive reperfusion therapy.Patients with 
LBBB and AMI are most likely to receive aspirin  and beta blockers 
than patients with AMI and no BBB .LBBB has been to shown to be 
associated with LAD occlusion upto 43% of patients  with LBBB and 
AMI. 
 Many physicians donot even attempt ECG diagnosis of AMI with 
LBBB because it is frequently taught that it is not possible.The 
notorious reputation of LBBB Ffor obscuring the diagnosis of AMI is 
due in large part to the difficulty of diagnosing previous MI in the 
presence of LBBB because  LBBB  alters Q wave patterns.Acute MI is 
also difficult to diagnose in the presence of LBBB because LBBB 
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typically manifests ST segment deviation.ST elevation due to the 
presence of AMI may be misinterpreted as due to LBBB and conversely 
the ST elevation of LBBB may be interpreted as due to AMI. 
Specific criteria for AMI  with LBBB 
 Specific criteria depend upon concordance and discornce 
.Consordance refers to the ST and or T wave being in the same 
direction as the majority of the QRS.ST and T wave discordance is the 
normal condition of LBBB.Although the presence of concordant T 
waves is abnormal and may be seen in AMI it is not very specific.The 
following morphologies have good specificity for LBBB with AMI and 
although the sensitivity is debated they have performed nearly as well 
in some studies as ST elevation for STEMI without LBBB 
 Concordant ST elevation >1 mm in one or more leads which 
means ST elevation in leads in which QRS is  predominatly positive 
[v5,v6,I,Avl,II].This is diagnostic of AMI  and contrasts with LBBB 
with no AMI  which manifests discordant ST  deviation 
 Concordadnt ST depression >1mm in one or more leads which 
means ST depression 
  In leads in which QRS is predominatly negative 
[V1,V2,V3,V4].This is 90% specific for AMI due to posterior injury 
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 Discordant ST elevation >5 mm and disproportionate with QRS 
voltage appears to be 85% to 90% specific for AMI.This contrasts with 
uncomplicated LBBB,in which discordant ST elevation is typically <5 
mm. 
Diagnostic changes from a previous ECG 
 AMI  superimposed on chronic LBBB may show diagnostic 
changes.If a prior ECG showed LBBB without ST segment deviation 
,new ST elevation is diagnostic of AMI.If a previous ECG shows LBBB 
with discordant ST segment deviation,increased ST elevation may be as 
sensitive for AMI as increased ST elevation in patients without 
LBBB.If no previous ECG is available for comparision record serial 
ECGS or perform continuous ST segment monitoring .Changwes 
typical of AMI on serial ECG or continuous monitoring may be 
diagnostic 
 Essential considerations in the management of suspected AMI 
with LBBB 
• Clinical suspicion of AMI 
• Specific Criterias [sgarbossa,Smith]for AMI 
• Availability of angioplasty 
• Thrombolytic Contraindications 
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Clinical Significance 
 LBBB  is usually secondary to underlying heart disease. 
Approximately  30% of patients due to heart failure . 
 70% had preceding evidence of LVH. 12% have no demonstrable 
heart disease.LBBB has higher mortality from heart failure and 
infarction even in persons with no overt heart disease.As the duration of 
QRS complex widens the risk of heart failure increases.Thre is  a higher 
risk of high grade atrioventicular block and cardiac death  nad one of 
the important cause of sudden cardiac death.Among patients with 
coronary artery disease LBBB signifies more exterior wall damage 
more severe LVD and increased mortality and morbidity 
 Patient with axis deviation have severe clinical 
manifestation.Left axis deviation is associated with severe conduction 
system because it includes fascicles and main left bundle .Right axis 
deviation suggests dilated cardiomyopathy with biventricular 
enlargement 
 The abnormal ventricular activation incites compromisd 
hemodynamic changes superimposing on the already diseased heart. 
There is premature movement of septum into left ventricle followed by 
delayed contraction of lateral and posterior  left ventricular wall. As a 
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consequence when the lateral wall contracts blood pushes the compliant 
septum towards right ventricular cavity than the outflow tract reducing  
the ejection fraction and efficiency. The dysynergy in left ventricle is 
severe with a delay of more than 60 msec between septum and lateral 
wall contraction is found in 60% of patients with QRS durations of 120 
to 150 msec and in 70% of those with QRS more than 150 msec 
 A major impact of LBBB it obscures or simulates other ECG  
patterns  . In LVH there is an increase in  amplitude of QRS duration 
and there is left axis deviation intrinsic to LBBB.In myocardial 
infarction the  emergence of abnormal Q waves with infarction is 
dependent on normal initial sequence of ventricular activation .In 
LBBB there is 1]absence of Q waves 2]low r wave amplitude in mid 
precordial leads3]ST T  wave changes 
All these can simulate anterior infarction pattern 
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CARDIAC BIOMARKERS 
 The diagnosis of acute MI is mainly made upon  ECG findings  
or clinical picture (angina) or cardiac biomarkers out of which the latter 
is more reliable as ECG can be non specific and clinical findings may 
not manifest. Therefore, the latest diagnosis of MI is made by elevated 
levels of cardiac biomarkers mainly CKMB and troponin T of which 
troponins are the preferred lot. 
 The diagnosis of MI using biomarkers depend upon a vast range  
of  criteria 
 The 99th percentile of the normal range of values should be the 
cutoff value for both troponin and CKMB  
 A rise and/or fall should be observed and a value greater than 3 
standard deviations is to be considered significant 
A significant change is always pathological 
 Cardiac troponins rise nearly 2-3 hours after acute myocardial 
injury and an aggregated assay along with other markers like ck-mb and 
myogobin which are rapid markers released during muscle damage, 
though non specific, can help in diagnosis of acute MI. 
 Cardiac troponin I and T vary in sensitivity and specificity for 
biochemical damage. 
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 Reversible and irreversible cardiac injuries are hypothesised to 
depend upon troponin and myoglobin values, and their relation is 
questioned. If biomarkers are produced the same way in both reactions 
the possibility in distinguishing them is reduced. 
 Troponn T and I are regulatory proteins that affect cardiac 
contractility by regulating calcium mediated channels and thereby 
affecting interactions between muscle proteins, actin and myosin and 
since they are products of a specific gene they are found to be unique 
for the myocardium out of which troponin I is even more specific as it 
is not found anhywhere except for cardiac tissue when compared to 
troponin T which may be found in certain groups of skeletal muscles 
too which accounts for slight elevation of troponin T during specific 
muscular damages which focusses the importance of assay of troponin I 
for diagnostic purposres. The store for troponin can be the cytosolic 
pool which accounts for its earlier release along with myoglobin and 
also structural pool  that accounts for its sustained release. 
 Any variations in sensitivity and specificity of the assay can be 
accountable to the variations in standardisation or to the presence of 
modified troponin T and I present in the serum pool or to the variation 
of cross reacting antibodies which leads to development of high 
sensitive or very highly sensitive assays which when not specified 
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shows the assay to be contemporary assays which calls for 
standardisation of an assay which makes the assays imprecise due to the 
very low values of cardiac markers otherwise found in the subjects (eg, 
0.01 to 0.5 mcg/l). 
 Young and healty individuals are found to have a small level of 
troponin elevated in ther blood which may be due to muscular activity 
which can again be questionable in an assay and defining normal range 
of troponin becomes even more difficult. Therefore an elevation above 
the 99th percentile is considered to be an increased cardiovascular risk 
 Diabetes mellitus, left ventricular hypertrophy, chronic kidney 
disease, and heart failure are the major predictors of elevated troponin T 
values and the incidence of cardiovascular mortality is found to be more 
in such cases 
 Elevated levels of biomarkers can also  be seen in supply demand 
abnormalities, hypertrophies of muscles and also in post operative and 
trauma patients which can give a false value in assays 
 Cardiac markers can be used for late diagnosis of infarctions or 
reinfarctions as tni can persist upto 10 days after an AMI favoring late 
diagnosis. Reinfarctions can be assessed by prompt re elevation of the 
troponin levels 
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 An immediate measurement of cardiac troponin is mandatory in 
case of a reinfarction and a 20 % increase in second sample values 
confirms it. 
 Though troponin elevation is a marker for AMI it can have varied 
differential diagnosis since elevation fits into even moderate to severe 
pulmonary embolism with acute right heart overload, heart failure, and 
myocarditis. 
 In many studies the infart sizes has been measured by the level of 
troponins thereby signifying their importance in assessing the size of 
infarct. 
 Troponin T and I are considered to be good markers of prognosis 
of mi too and has equal range of depletion or change after an MI this 
was studied in the GUSTO 3 trials and repeat after 30 days showed 
subsequent regression in values of troponins studies have also showed 
that an increased rate of cardiac deaths are found in patients with 
elevated levels of troponins  
 In metaanalyses of deaths in patients with elevated troponin 
levels, a patient with elevated troponin T is found to be at higher risk of 
death when compared to the ones with an elevated troponin I value. 
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 Persistent occlusion of the culprit vessel and a reduced left 
ventricular ejection fraction are associated with an increase in troponin 
value 
 Creatine kinase a biomarker that exists in M and B isomer forms 
and is a clinical guide in assessing the destruction of muscle tissues and 
is therefore not specific for MI. Though sensitivity and specificity are 
less for CKMB it is utilized because of easy and rapid assessment. 
A negative analysis can turn up as CKS are elevated also in 
certain muscular dystrophies, adenomyositis and poliomyositis which 
can act as a differential diagnosis for ami in terms of elevated serum 
biomarkers. 
 They elevate usually at about 4- 6 hours after the cardiac injury 
but may not be  elevated upto 12 hours in some patients. It returns to 
baseline in over 36 to 48 hours but they have to be excluded in cases 
with skeletal muscle injury as such injuries themselves can cause an 
elevation in the b fraction of CKMB and therefore in CK level. 
 The grade of reperfusion can also be assesed with the elevated 
levels of CK. 
 Resampling of CKMB can be used to assess reinfarction along 
with troponin as it is elevated in such cases 
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 A crusade initiative in UK did studies on the same the findings 
are as follows 
1. "Results in them were discordant in 28 percent of patients. The more 
sensitive was troponin, as 18 percent had normal CK-MB values but 
elevated troponin. In addition, 10 percent had false positive CK-MB 
elevations, as defined by normal troponin values." 
2. "Compared to patients who were negative for both biomarkers, in-
hospital mortality was not increased in patients who were troponin-
negative and CKMB-positive (ie, false positives; 3.0 versus 2.7 
percent, adjusted odds ratio 1.02, 95 percent CI 0.75-1.38)." 
3. "Compared to patients who were negative for both biomarkers, there 
was a nonsignificant trend toward increased mortality in patients 
who were troponin-positive /ck-mb-negative (4.5 versus 2.7 percent, 
adjusted odds ratio 1.15, 95 percent CI 0.86-1.54) and a significant 
increase in mortality in patients who were positive for both 263+ 
Biomarkers (5.9 versus 2.7 percent, adjusted odds ratio 1.53, 95 
percent CI 1.18-1.98)." 
 The studies finally conclude the superiority of troponin over CK-
MB and the use of cardiac biomarkers in assesing the time of AMI, the 
size of infarct,the amount of reperfusion and the prognosis of MI.   
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ECHOCARDIOGRAPHY IN REPERFUSION DECISION 
Inadequate coronary blood flow leads to ischemic myocardium and 
abnormal contraction or regional  wall motion abnormalities which is 
detectable with echocardiography.A wall motion abnormality may 
manifest as hypokinesis [decreased wall motion]akinesis[no wall motion] 
or dyskinesis[bulging] or aneurysmal diastolic distortion. 
 
 
Fig 10 : Wall motion abnormalities on echo. 
 
 The presence of a WMA cannot distinguish AMI from old MI. 
However when the ECG differential diagnosis is AMI versus  “old MI 
with persistent ST elevation”,the presence of diastolic distortion with 
myocardial thinning and dyskinesis strongly supports a diagnosis of old 
MI 
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The presence of new regional WMA supports the diagnosis of 
myocardial ischemia and in conjunction with new ST elevation in the 
corresponding ECG location, strongly suggests STEMI. A new WMA in 
conjunction with equivocal ECG, in the right clinical setting is an 
indication for reperfusion.  Normal wall motion rules out large risk area 
but echocardiography is insensitive for small risk areas, so normal wall 
motion in the presence of diagnostic ECG doesn’t rules out a small 
STEMI. Nonethless in the presence of an equivocal ECG, normal wall 
motion on an echocardiogram of good quality detected by a skilled 
technician and interpreter woulD provide evidence against AMI and be a 
good reason to withhold thrombolytics. 
Almost all the segments of the left ventricle can be visualized by by   
parasternal. apical and sometimes subcostal windows. For the purpose of 
regional wall motion analysis wall motion score index is calculated to 
quantify the magnitude of region wall motion abnormalities. 
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Fig 11 : Views of Heart 
Echo in Acute Myocardial Infarction  
In patients with acute coronary echocardiography has several purposes 
1) For the  diagnosis or excluding  acute MI in patients with persistent  
angina and when the  ECG    is  ambiguous. 
2) Quantifying the magnitude of the myocardial segment  at risk and 
the ultimate infarct size after reperfusion 
3) Evaluating the complication of Infarct 
4) Assesing the viability of the affected myocardium 
5) Risk stratification 
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2D echocardiogram are helpful in following up the reperfused 
myocardial or expansion of the infarct size  in patients with 
STEMI.Prolonged akinesis doesn’t mean failure of reperfusion.In these 
cases low dose dobutamine contrast or strain imaging may be helpful in 
detecting viability. 
ECHOCARDIOGRAPHY AND ECG 
Echocardiography helps in evaluation of ischemic symptoms and in 
reperfusion decisions in following conditions. 
1. Non specific ST elevation consistent with AMI 
a. If there is a new WMA patient is a candidate for reperfusion 
therapy. 
b. If wall motion is normal it makes AMI of large risk area unlikely 
2. Precordial ST depression that is consistent with either posterior 
STEMI or anterior UA/ NSTEMI 
a. If there is a new posterior WMA the patient is a candidate for 
reperfusion therapy. 
b. If there is new anterior WMA it is indicative of an UA/ NSEMI 
not indicating thrombolytic therapy 
3. When ECG is non specific for any kind of ACS then the patient is 
not eligible for thrombolytics but is indicative of angiography 
+_PCI 
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4.  When ST elevation an QS waves are present and differential 
diagnosis is AMI versus ventricular aneurysms 
a. Presence of diastolic distortion and myocardial thickening 
supports ventricular aneurysm and ST elevation is probably 
old. 
b.  Akinesis or hypokinesis without diskinesis however does not 
necessarily imply that ECG findings are new. 
LIMITATIONS OF ECHOCARDIOGRAPHY 
1. Echocardiography cannot differentiate between a STEMI 
and UA/ NSTEMI 
2. Echocardiography cannot determine the time course of 
AMI. 
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HISTORICAL PERSPECTIVE 
 Recognising left bundle branch block in Acute myocardial 
infarction was made by Oppenheimer and Rothschild way back in 
1917.Patients with LBBB presents an unique problem in that they are 
relatively older with other co morbidities like systemic hypertension, 
Diabetes Mellitus, Heart failure etc.Even though there is an observed 
increased mortality in these subgroups .question remains whether it is 
due to confounding factors like age and other comorbid conditions 
 Diagnosis of MI  in the background of LBBB always remains 
challenging as activation of left ventricle happens  much later and the 
initial wavefront  activating the septum moves from right to left  and as 
a consequence the Q waves the signature of AMI are absent. Also 
secondary  ST T wave  abnormalities  obscures injury currents of 
ischemia and infarction 
 In 1996 sgarbossa came out with the electrocardiographic criteria 
for the diagnosis of Myocardial Infarction in patients with Lbbb and 
came out with the concept that ST deviation is the ony useful 
electrocardiographic  finding  that would be helpful in the diagnosis of 
Acute MI in LBBB.They reviewed 26,003 patients  enrolled in GUSTO 
1 [Global Utilization of Streptokinase and Tissue Plasminogen 
Activator of Occluded Coronary Arteries] and compared people who 
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had LBBB with Acute MI  with electrocardiograms of control patients 
who had chronic coronary artery disease and left bundle branch block. 
Derivation set included 131 patients [0.5%] with LBBB.Average time 
from onset of symptoms to ECG was 120 minutes. Validation set  was 
45 patients from GUSTO 2A with AMI and LBBB. 
 Concept of concordance and discordance: It refers to whether the 
last portion of QRS complex goes in the same direction as that of T 
wave .Discordance is the rule which denotes secondary changes. 
Concordance is always due to  primary ischemia/inf arction.  
 
 
 
 
 
Fig 12 : Normal Discordance 
 They came out with a cut off point for ST segment deviation that 
would differentiate between LBBB  patients  with acute infarction and 
those without infarction in the absence of previous ECGS. 
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Identified three predictive criteria 
1) “ST segment elevation  greater than or equal to 1mm concordant 
with QRS 
2) ST segment depression greater or equal to 1mm concordant with 
QRS 
3) ST segment elevation greater than or equal to 5mm discordant with 
QRS” 
 
             
 
 
 
Fig 13 : Sgarbossa's Criteria 
Of these the ST elevation concordant with major QRS deflection I any 
lead had odds ratio for AMI  of 25.2       and ST depression in the the 
anterior leads v1 v2 or v3  had odds ratio for AMI  of 6 .Discordant ST 
segment elevation of 5mm or more in any lea had a weaker association 
of odds ratio of 4.3.when combined together these three criteria had a 
sensitivity  of 78% and specificity of 90%. 
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 The presence of LBBB in patients with acute MI almost always 
associated with increased morbidity and mortality.If its new then it is 
due to occlusion of proximal LAD which means an extensive anterior 
wall MI with a large volume of myocardial involvement.If its an old 
LBBB it’s a strong marker of compromised left ventricular dysfunction 
and any further loss of myocardial involvement will lead to 
hemodynamic jeopardy. 
MODIFIED SMITHS CRITERIA 
The low sensitivity in Sgarbossa criteria is due to  
The study is based on the enzyme diagnosis of Infarction and not 
angiography so the infarction group included both ST elevation 
and Non ST elevation Infarction 
1) Anterior MI is diagnosed by elevation of ST segments in  v1 to 
v4. In LBBB there is a preexistent discordant ST elevation.The 
excessive ST elevation has to be assessed for concluding a 
diagnosis of  most anterior Myocardial Infarction.Sgarboss used 
an absolute numerical value of 5mm for discordant ST elevation. 
2) Smith proposed instead of using an absolute value  use of a 
proportion criteria [any ST segment elevation to S ratio of less 
than 0.25 with atleast 1mm ST elevation improves the prediction 
of  coronary occlusion. 
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3) 162 patients  with LBBB chest pain  were studied of which 33 
had angiographic evidene of coronary occlusion. And 129 were 
control group.The new criteria has a positive likelihood of 9 and 
negative likelihood of 1. 
Anterior Myocardial Infarction caused by occlusion of left 
anterior decending artery  results in ST elevation in the leads v1 to v4 
and may be in v5 , I,Avl if the occlusion is proximal to diagnol artery.In 
LBBB there is already a preexistence discordance with baseline ST 
elevation in  V1 TO V4.In the setting of mid LAD occlusion the 
diagnosis of STEMI will be purely based on excessive discordance in 
v1 to v4.Sgarbossas weighted criteria gives only 2 points to this 
discordance rule and hence will miss a  large number of infarctions..By 
replacing this absolute criteria with proportion criteria the sensitivity 
greatly improved 
In this derivation study  the ratio of  ST segment elevation to S 
ratio proved to have significantly better sensitivity and accuracy than 
that of the maximum ST  segment elevation. 
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Fig 14: Modified sgarbossa 
 FTT collaborative group:. Indications of fibrinolytic therapy in 
suspected Acute MI ;collaborative overview of early mortality and 
major morbidity results from from all randomized trials of more than 
thousand patients 1994  
 Methods: FTT collaborative group reported the combined results 
of all 9 placebo controlled thrombolytic trials including ISIS 2 and 
GEISSI 1 . 
 Findings of 2146 cases of BBB,35day mortality for the 
thrombolytic group was 18.7 % v/s 23.6 % for placebo.The benefit 
associated with thrombolytic therapy for typical chest pain with LBBB 
far outweighs the associated risks 
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 Comment - the benefit of thrombolytics for suspected and BBB 
was demonstrated almost 15 years ago , in the intervening years 
physicians have come to recognise atypical chest pain as a symptom of 
AMI and probably obtained many more ECGS than in the past .Though 
it has never been shown and would be impossible to show suspected 
AMI today may have a more liberal definition in the minds of 
physicians than 15 years ago .If so the pretest probability of AMI is 
lower and the recommendations for thrombolysis for every patients 
suspected AMI and LBBB would be too liberal , perhaps this accounts 
for the low prevalence  of AMI with LBBB in Kontos et al, Li et al and 
Ozment et al .a more appropriate indication for reperfusion therapy is 
for those patients with symptoms suspicious for persistant coronary 
occlusion who have LBBB not known to be old.  
 Studies suggesting the utility of specific ECG criterion for AMI 
in LBBB IS low: 
 Shlipa MG et al. should the electrocardiogram be used to gate 
therapy for patients with LBBB or suspected MI? 
 Methods Shlipak et al retrospectively applied the algorithm of 
sgarbossa et al to 83 patients with LBBB who presented with acute 
chest pain, acute pulamonary oedema or cardiac arrest. AMI was 
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diagnosed by CKMB of 7ng/ml or cardiac troponin cTnI of 1.5 ng/ml or 
more . 
 Comment - this biomarker elevation will be caused by cardiac 
arrest or pulmonary oedema without coronary occlusion. 
 Findings - Sgarbossa criteria was insensitive for myocardial 
damage so defined . The results of this study was extrapolated to 
indicate every 1000 patients with LBBB and clinical presentation 
suggetive of AMI ,926 would survive without major stroke if all 
patients recieved thrombolysis . This is incontrast to the stroke free 
survival of only 918 patients if the scarbossa criteria was used to 
determine therapy. 
 Comment - The calculation was based on over high excess high 
stroke rate of 8.4v% per thousand. The actual overall excess non fatal 
stroke rate for tPA is closer to 3.5 per thousand if both infarct and 
haemorrhage are considered 
Kontos  the MC et al .Can Myocardial Infarction be rapidly identified 
in emergency department patients whi have left bundle ?  2001 
Methods  Kontos et al evaluated 7725 patients with ischemic symptoms  
over 6 years .They reviewed the incidence of LBBB ,LBBB and 
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AMI,and predictors of AMI in the presence of LBBB with special 
attention to new versus old LBBB and to Sgarbossa criteria. 
 Findings:LBBB was found in 182 patients.AMI was diagnosed in 
24.Presence of one or more of the Sgarbossa criteria had sensitivity of  
46% specificity of 93% PPV  of 50% and NPV of  92%.New or 
indeterminate age LBBB had sensitivity of 83% specificity of 41%,PPV 
of 18% and NPV of 94%.Addition of positive initial CK MB to 
Sgarbossa criteria improved sensitivity to 63% with a specificity of 
99% and PPV and NPV of 88% and 94%.Mean peak total CK and 
CKMB   were 2750 IU/L and 212 ng/ml in the group with positive 
criteria and 370 IU/L and 32 ng/ml in the group without criteria though 
use of reperfusion therapy is not stated. 
 Comment: The authors considered the sensitivity of criteria 
unacceptably low identifying only 11 of 24 patients with AMI yet also 
having a poor PPV.They also were of the opinion that LBBB not known 
to be old performed poorly.  
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Table 2 : Prevalence of LBBB and AMI in studies of patients with suspected 
ACS 
Study Year Total, no. of 
patients 
No. of patients 
with LBBB (%) 
No. of LBBB 
patients with 
AMI (%) 
Sgarbossa et al. 
(1) 
1996 26,003 145 (0.6) 131 (90) 
Cannon et al. (2) 1997 1,416 127 (9) 40 (31) 
Wong et al.[ 3) 2005 17,073 300 (1.8) 242 (81) 
Al-Faleh et al. [4] 2006 22,839 267 (1.2) 158 (63) 
Lopes et al. [5) 2011 5,742 98 (1.7) 85 (87) 
Jain et al. [6] 2011 892 36 (4) 12 (33) 
Subtotal (n=6)  73,965 973 (1.3) 668 (67) 
 
Based on the previous studies the incidence of LBBB in those 
seeking medical attention for suspected acute coronary syndrome was 
2%.Comparring to those patients without bundle branch block these 
patients tend to be older ,with associated comorbid conditions like 
diabetes,hypertension etc[18,20].Also patients with LBBB tend to have 
poor prognosis with adverse consequences like recurrent 
MI,stroke,death compared  to those without LBBB.But it should be kept 
67 
 
in mind these cannot be contributed to LBBB itself rather it is the 
underlying preexisting pathology that caused the 
LBBB[structural,ischemic heart diseases ]must be held responsible for 
the worse outcome.Since LBBB is more prevalent among the elderlies  
which in turn associated with other co morbidities LBBB can be 
considered one contributing integrative co factor than a independent 
cause for mortality or morbidity. Compared to left bundle branch block, 
Right Bundle Branch Block had higher mortality rate and the 
independent mortality risk of LBBB yet to be proved.[1,21] 
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Table 3 : Representative studies of patients with suspected AMI 
presenting to emergency department 
Study Year Total, no. of 
patients 
No. of patients 
with LBBB (%) 
No. of LBBB patients with AMI 
(%) 
Fesmire et al. (53) 1989 440 24 (5.5) 3 (13) 
Otto and 
Aufderheide (54) 
1994 428 18 (4.2) 5 (28) 
Kudenchuk et 
al.(55) 
1998 3,027 57 (1.9) 20 (35) 
Edhouse et al. (56) 1999 797 50 (6) 26 (52) 
Shlipak et al. (39) 1999 n/a 83 (100) 26 (31) 
Li et al. (15) 2000 n/a 190 (100) 25 (13) 
Kontos et al. (14) 2001 7,725 182 (2.4) 24 (13) 
Gunnarsson et al. 
(43) 
2001 n/a 158 (100) 76 (48) 
Maynard et al. (57) 2003 n/a 56 (100) 18 (32) 
Chang et al. (31) 2009 7,937 191 (2.4) 11 (6) 
Bansilal et al. (1) 2011 2,271 102 (4.5) 5 (5) 
Kontos et al. (34) 2011 n/a 401 (100) 116 (29) 
Subtotal (n=13)  26,322 802 (3.0) * 437 (26) † 
Total (n=19)  100,287 1,775 (1.8) * 1,105 (42) ‡ 
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A substantial amount of patients of suspected acute coronary 
syndrome did not have a culprit artery occlusion on angiogram and 
should have been considered as non ACS cause/Unstable angina or 
NSTEMI. This has a significant clinical implication because these 
patients would have been unnecessarily subjected to thrombolysis or 
angiogram and and thrombolysis would have been proved harmful in 
case of NSTEMI. 
 
 
 
The 1996 and 2004 guidelines for STEMI were based on the  pooled 
analysis of nine fibinolytic trials  which stated that those patients with 
suspected  coronary syndrome presenting with bundle branch block on 
admission had higher mortality rate and would show maximum decline in 
mortality rate if started on early fibinolytics.This  lended more statistical 
strength to the patient with bundle branch block and thus  formed the basis 
for formulation for the guidelines for new or presumably new onset LBBB 
to be treated as STEMI equivalents. 
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          The greatest limitation for this study is that they didn’t  discriminate  
between type and  chronicity  of bundle branch block.Another    limitation 
is that these early fibrinolytic trials were based on less reliable enzymatic 
markers[CKMB] which can be raised in other non ischemic conditions 
also. 
              Hackel DB,Wagner G Ratliff NB et al  made an important 
observation that the new onset LBBB if its due to MI,the the most 
proximal artery will be involved with greater the magnitude of 
myocardium involved and the patient would be in acute pulmonary 
edema or would be in Shock. 
               With the advent of angiography the new trials categoricaly 
proved left bundle branch didnt predict the increased risk of AMI. 
Larson et al study claimed 44% of the patient with new LBBB on 
subsequent angiogram didn’t have culprit occluded artery.Chang et al 
study found no difference in incidence of MI between new onset  and 
old  and with no LBBB [7.3% vs 5.2% vs 6.1%] 
Newer 2013 guidelines has taken into consideration all these 
factors and  has removed the new LBBB as an indication for 
reperfusion therapy.It categorically states that new onset LBBB is not 
diagnostic of AMI by itself 
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METHODOLOGY 
Study Centre 
Coimbatore Medical College Hospital, Coimbatore 
Study Period 
July 2014 – June 2015 
Sample Size 
50 
Inclusion Criteria 
a. Patients of any gender above or equal to 30 years of age at the time 
of hospital admission 
b. Patients presenting with typical anginal pain and suspected Acute 
coronary syndrome 
c. Ecg shows Left Bundle Branch Block  
Exclusion Criteria 
a. Patients below 30 years of age  
b. Patients in acute Heart Failure 
c. Hemodynamically unstable patient 
Study Design 
Short-term prospective study 
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Method of Data Collection 
A total of of fifty(n = 50)  patients who were hospitalized for 
suspected acute coronary syndrome as well as satisfied our inclusion and 
exclusion criteria were selected for the study.  
Data collected included Demographics,History,ECG, and cardiac 
markers -Troponin T. 
Electrocardiograms were classified according to standard guidelines 
as Left Bundle Branch Block not known to be old[new or presumably new 
onset]  and LBBB known to be old. 
Smoker is defined as one who has smoked within the previous one 
year irrespective of duration of smoking.  
Acute Heart failure  is defined as the occurrence of acute 
decompensation of heart function for the first time in patient’s life.  
A patient is said to be Hemodynamically unstable if the systolic 
blood pressure is below 90 mm hg or a decrease in mean blood pressure 
by 30 mmhg 
A patient is said to be hypertensive if he/she is already on 
antihypertensives, and/or if he/she has a high blood pressure documented 
in the past, and/or if there are signs of long standing hypertension in 
fundus, ECG, chest X-ray and echocardiogram. JNC VIII guidelines are 
followed for diagnosing systemic hypertension [74]. 
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A patient is said to be diabetic if he/she is already on oral 
hypoglycemic agents or insulin therapy, and/or if he/she has a high 
random/fasting blood sugar value or has a high HBA1c value or has an 
abnormal oral glucose tolerance test documented in the past, and/or if 
he/she has elevated blood sugar values during hospital stay. The 2014 
guidelines of American Diabetic Association are followed for diagnosing 
diabetes mellitus. 
A patient is said to have coronary artery disease if he/she is already 
on antiplatelet drugs and nitrates, and/or if he/she has coronary artery 
disease documented in the past, and/or if he/she has signs of new onset 
and/or old coronary artery disease in ECG, Echocardiogram and/or 
percutaneous coronary angiogram.  
A patient is said to have dyslipidemia if he/she is already on anti-
dyslipidemic drugs such as statins, and/or if he/she has high lipid profile 
values documented in the past, and/or if he/she is found to have high lipid 
profile values on admission. 
Investigations 
Blood sugar  
Lipid profile  
Chest X-ray PA view 
12-lead electrocardiogram 
Cardiac Markers – Troponin– T  
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Transthoracic echocardiogram  
The above investigations were done in all patients. Other laboratory 
and imaging investigations, if needed, were done on a case-by-case basis 
in selected patients.  
Statistical analysis: 
Multivariate linear regression analysis with 95% confidence 
interval (CI) will  be done for statistical analysis. Data are expressed in 
mean ± SE (Standard Error). P value <0.05 will be taken as statistically 
significant. All these analysis will be performed by using a commercially 
available software Statistical Package for the Social Sciences (SPSS) on 
personal computer 
 
 
 
 
 
 
 
 
 
 
75 
 
RESULTS AND OBSERVATIONS 
Age in relation to occurrence of new onset and old LBBB 
 LBBB 
Total 
NEW OLD 
Age 
MORE THAN 
50 17 26 43 
LESS THAN 
50 6 1 7 
Total 23 27 50 
P=0.023 significant 
Table 4 : Age in relation to occurrence of new onset and old LBBB 
73.9% of people with new lbbb are more than 50 years of age 
96.3% of people with old lbbb are more than 50 year of age.  Older age 
has higher history of old lbbb which shows as age progress incidence of 
lbbb is high 
 
CHART 1 : Age in relation to occurrence of new onset and old LBBB 
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Gender in relation to new onset and old LBBB 
 
Sex       LBBB Total 
New Old 
Male  18 17 35 
Female  5 10 15 
Total 23 27 50 Total 
 
Table 5: Gender in relation to new onset and old LBBB 
 
NEW OLD
OLD; 17
NEW; 5
OLD; 10
     MALE 
FEMALE
 
CHART 2 : Gender in relation to new onset and old LBBB 
 
78.3% of patients with new LBBB were males whereas 62.96% of 
patients with old LBBB were males 
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TROPONIN CORRELATION IN OLD AND NEW ONSET LBBB IN 
SUSPECTED ACUTE CORONARY SYNDROME 
 LBBB Total 
NEW OLD 
TROPT (+) 2 2 4 
(-) 25 21 46 
Total 27 23 50 
 
TABLE 5 : Troponin Correlation In Old And New Onset LBBB  In 
Suspected Acute Coronary Syndrome 
 
NEW LBBB OLD LBBB
0
5
10
15
20
25
2 2
21
25
TROPONIN T
TROP T POSITIVE TROP T NEGATIVE
 
CHART 3 : Troponin correlation in old and new onset LBBB  in 
suspected acute coronary syndrome 
                                                    P=0.867 
OR=0.840 
8.7% of the people with new LBBB were troponin positive while 7.4% of 
the patient with old LBBB had Troponin positivityNo Significant 
Difference In Incidence Of  MI in  Both New onset And Old LBBB in 
suspected Acute coronary syndrome 
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DIABETES MELLITUS ASSOCIATION IN NEW ONSET AND 
OLD LBBB IN SUSPECTED ACUTE CORONARY SYNDROME 
      LBBB Total 
NEW  OLD 
     DIABETIC  16 17 33 
NON 
DIABETIC 
7 10 17 
Total 23 27 50 
 
Table  6 : Diabetes mellitus association in new onset and old LBBB in 
suspected acute coronary syndrome 
 
              NEW OLD
NEW; 16
OLD; 17
NEW; 7
OLD; 10
     DM
NON DM
 
CHART  4 : diabetes mellitus association in new onset and old LBBB in 
suspected acute coronary syndrome 
69.56% OF PATIENTS WITH NEW  LBBB HAD DM WHEREAS 
62.96% WITH OLD LBBB HAD DM 
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PRIOR CABG / PTCA  ASSOCIATION IN NEW ONSET AND 
OLD LBBB IN SUSPECTED ACUTE CORONARY SYNDROME 
 LBBB Total 
NEW OLD 
PRIOR 
CABG/PTCA 
Yes  3 4 7 
No 20 23 43 
Total 23 27 50 
 
Table 7 :  Prior CABG / PTCA  association in new onset and 
old LBBB in suspected acute coronary syndrome 
P = 0.857 
OR = 0.863 
 
NEW
OLD
NEW; 3
OLD; 4
NEW; 20
OLD; 23
PRIOR CABG/PTCA NO PRIOR CABG/PTCA
 
 
CHART 5 : Prior CABG / PTCA  association in new onset and 
old LBBB in suspected acute coronary syndrome 
 
13% Of Patients With New  LBBB Had Prior History Of CABG/PTCA  Whereas 
14.81% Of With Old LBBB Had Prior History Of CABG/PTCA 
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PRIOR MI ASSOCIATION IN NEW AND OLD LBBB IN A 
SUSPECTED ACUTE CORONARY SYNDROME 
  LBBB Total 
NEW OLD 
Prior 
MI 
Yes 5 8 13 
No 18 19 37 
Total 23 27 50 
Table 8 : Prior MI association in New and Old LBBB in a suspected acute coronary 
syndrome 
P = 0.526 
OR = 0.660 
21.73% of patients with new  LBBB had prior history OF MI whereas 29.62% 
of with old LBBB had prior history of MI 
 
 
 
 
 
 
 
 
Chart 6 : Prior MI association in New and Old LBBB in a suspected acute coronary 
syndrome 
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CAHD ASSOCIATION IN NEW ONSET AND OLD LBBB IN 
SUSPECTED ACUTE CORONARY SYNDROME 
 NEW 
LBBB 
OLD 
LBBB 
 
    
CAHD 
Yes 13 17 30 
No 10 10 20 
Total 23 27 50 
Table 9 : CAHD association in new onset and old LBBB in suspected acute coronary 
Syndrome 
                                                      P = 0.643 
                                                    OR = 0.765 
56.52% of patients with new  LBBB had prior history of CAHD whereas 
62.96% of with old LBBB had prior history of CAHD 
 
Chart 7 : CAHD ASSOCIATION IN NEW ONSET AND OLD LBBB IN 
SUSPECTED ACUTE CORONARY SYNDROME 
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VALVULAR HEART DISEASE ASSOCIATION IN NEW ONSET AND OLD 
LBBB IN SUSPECTED ACUTE CORONARY SYNDROME 
       LBBB Total 
NEW  OLD 
Valvul
ar 
1 2 2 4 
2 21 25 46 
Total 23 27 50 
Table  10 : valvular heart disease association in new onset and old LBBB in suspected 
acute coronary syndrome 
P = 0.867 
OR = 1.190 
8.69% of patients with new  LBBB had history of Valvular heart disease 
whereas 7.4% of with old LBBB had prior history of Valvular heart disease 
 
     Chart 8 :     Valvular heart disease association in new onset and old LBBB in 
suspected acute coronary syndrome 
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SYSTEMIC HYPERTENSION ASSOCIATION IN NEW ONSET 
AND OLD LBBB IN SUSPECTED ACUTE CORONARY 
SYNDROME 
      LBBB Total 
NEW OLD 
SHT 1 17 21 38 
2 6 6 12 
Total 23 27 50 
Table  11: Systemic hypertension association in new onset and old LBBB in suspected 
acute coronary syndrome 
P = 0.750 
OR = 0.810 
73.91% of patients with new  LBBB had prior history of hypertension  whereas 
77.77%% of with old LBBB had prior history of hypertension 
 
Chart 9 : Systemic hypertension association in new onset and old LBBB in suspected 
acute coronary syndrome. 
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HYPERLIPIDEMIA ASSOCIATION IN NEW ONSET AND OLD LBBB IN 
SUSPECTED ACUTE CORONARY SYNDROME 
 LBBB Total 
NEW OLD 
Hyperlipide
mia 
    
Yes 
8 10 18 
    
No 
15 17 32 
Total 23 27 50 
Table 12 : Hyperlipidemia association in new onset and old LBBB in suspected acute 
coronary syndrome 
                                                    P = 0.869 
                                                    OR = 0.907 
Hyperlipidemia doesn’t have significant influence on LBBB among this study 
group there is no significant difference two groups on relation between hyperlipidemia 
and LBBB 
34.78% of patients with new  LBBB had prior history of hyperlipidemia  
whereas  37.03%% of with old LBBB hadprior history of hyperlipidemia 
 
 
 
 
 
 
 
 
CHART 10 : Hyperlipidemia association in new onset and old LBBB in suspected 
acute coronary syndrome 
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SMOKING      ASSOCIATION IN NEW ONSET AND OLD LBBB IN 
SUSPECTED ACUTE CORONARY SYNDROME 
       LBBB Total 
NEW OLD 
Smoker Yes 16 17 33 
No 7 10 17 
Total 23 27 50 
Table 13 : Smoking  association in new onset and old LBBB in suspected acute 
coronary syndrome 
P = 0.623 
OR = 1.345 
69.56% of patients with new  LBBB had were smokers whereas  62.96% of 
with old LBBB were smokers 
 
 CHART 11 :  Smoking  association in new onset and old LBBB in suspected acute 
coronary syndrome 
                          
FAMILY HISTORY  OF MI ASSOCIATION WITH NEW AND OLD LBBB  IN 
A SUSPECTED ACUTE CORONARY SYNDROME.   
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       LBBB Total 
NEW OLD 
Family 
History 
of  MI 
Yes 7 10 17 
No  16 17 33 
Total 23 27 50 
Table 14 : Family history  of MI association with new and old LBBB  in a suspected 
Acute Coronary Syndrome 
P = 0.623 
OR = 0.744 
30.43% of patients with new  LBBB had family history of CAHD whereas 
37.03%  of patients  with old LBBB had family history of CAHD 
 
Chart 12 : Family history  of MI association with new and old LBBB  in a suspected 
Acute Coronary Syndrome 
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TIMI SCORE  ASSOCIATION WITH NEW AND OLD LBBB  IN A 
SUSPECTED ACUTE CORONARY SYNDROME 
 LBBB Total 
NEW  OLD 
TIMI 
SCORE 
0-1 7 7 14 
1-3 11 14 25 
>-4 5 6 11 
Total 23 27 50 
Table 15 : TIMI score  association with new and old LBBB  in a suspected acute 
coronary syndrome. 
                                                            P = 0.936 
TIMI score  doesn’t have significant influence on LBBB among this study 
group there is no significant difference two groups on risk of incidence of mi based on 
TIMI score 
 NEW LBBB OLD LBBB 
TIMI 
SCORE 
0-1 30.43% 25.92% 
2-3 47.82% 51.85% 
>_4 21.73% 22.22% 
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Chart 13 : TIMI score  association with new and old LBBB  in a suspected acute 
coronary syndrome. 
 
 
                                                     
 
 
 
 
 
         
 
 
89 
 
DISCUSSION 
 We concluded that new or presumed Left bundle branch need  
not imply that the patient has a acute myocardial infarction.  The previous 
studies which were the basis for the development of the guidelines before 
2013  relied on patients enrolled in large randomized studies.  It is 
therefore quite logical to conclude these patients enrolled in registries are 
different from actual patients presenting to casualty  with acute chest 
syndrome. 
 We conclude the incidence of MI  in new onset  LBBB is not 
significantly different from those that of people  with old LBBB. But 
many studies  predicted  worse outcome in  AMI  with new LBBB  than 
with old LBBB.  
 Prior guidelines recommend reperfusion for new or presumed 
new LBBB. But  it need not be  as our study suggests the rate MI is not  
different in people with new or old LBBB. Primary PCI is a more 
reasonable approach because it will aid in both diagnosis and also in 
intervention if any is needed. 
  New diagnostic  methods are the need of the hour for selecting 
candidates for reperfusion. The need for new strategies are far more 
greater in centres with  out primary PCI facility as the complication in 
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fibrinolytic therapy is much greater than that of falsely activating cath 
lab.Potential strategies include 
                                 1]Different algorithmic approach for cath lab 
activation  for  a Patient with LBBB  with acute chest syndrome than than  
the patient with a ST segment elevation myocardial infarction 
                               2]Use of more focused ,specified ECG criterias 
[Sgarbossa,Modified Smith criteria] 
                             3]Wide spread use of cardiac bio markers 
                            4]Use of bed side echo 
  If the time interval between first medical  contact and balloon is 
less than 120  minutes PCI is far superior to fibrinolysis  given the 
dreaded complications of fibrinolysis.If the interval exceed 2 hours onsite 
fibrinolysis is beneficial.But this may not be applicable to patients with 
LBBB because many of them dont have MI and LBBB itself has inherent 
risk of bleeding[with  preexistent heart disease,hypertension,heart 
failure]For these patients PCI is the preferred  strategy and fibrinolysis 
should be considered with utmost  caution if the likelihood of MI is very 
high! 
  Testing cardiac biomarkers,    specifically the cardiac   troponins I 
and T, is promising  in the diagnosis of AMI with LBBB. In recent years, 
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the analytic sensitivity for  troponin detection  has improved hundredfold . 
Newer assays have improved  sensitivity  as well, which enables 2  
troponin titres with a minute  difference  of few picograms per milliliter to 
be reliably differentiated. This is significant  because mere   rise in cardiac 
troponin can be found in many chronic cardiac and noncardiac conditions, 
and thus not specific AMI, a fast rise in absolute levels of troponin 
strongly supports the diagnosis of an evolving AMI . A serial fast rise in 
troponin in a patient with LBBB, especially in the background  of ongoing 
chest discomfort, may denote a hidden  STEMI and may prompt further  
testing such as bedside echocardiography ,primary PCI , or fibrinolytic 
therapy if PCI is not available.  
            In contrast, a more slow rise and lower peak in troponin levels 
may signal an NSTEMI (in which case, transfer to a PCI-capable facility 
still would be recommended typically), whereas a static troponin level 
would suggest a non-ACS cause.  Although there are limited datas, it is 
necessary  to hasten  the timing of enzyme assessment, so that 
measurements are performed every 15 min, rather than every 60 to 90 
min, in patients with LBBB and suspected AMI. Such an approach would 
shorten the   delay in reperfusion  in those ultimately determined to have 
STEMI equivalents. Assessment of serial  rapid biomarker measuremen , 
should be the focus of additional study in patients with suspected AMI and 
LBBB. 
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Table : 17 Algorithmic approach for patients with suspected Acute 
Coronary Syndrome and new onset LBBB 
 
 
             A new diagnostic and triage algorithm has been proposed  
considering the new guideline recommendations for a suspected acute 
coronary syndrome patient in the setting of new onset LBBB.If the patient 
is in cardiogenic shock or in acute heart failure ,Myocardial Infarction is 
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strongly suspected   and early reperfusion  should be promptly 
started.Sgarbossa criteria has been extremely helpful in detecting 
myocardial Infarction because of its reduced false positive rates and high 
specificity.If the  sgarbossa  score is 3 the patient can be confidently 
considered acute MI and reperfusion therapy can be started.If the score is 
less than two,then the smiths criteria shold be used anf if the ST/S ratio is 
less than or equal to 0.25  then the patient is a candidate for reperfusion.If  
none of the criteria is met ,Patient should be evaluated further with serial 
ECG monitoring,serial troponin levels and bed side echocardiography.If 
there is ST segment changes in serial electrocardiograms or rapid rise in 
troponin levels or there is any wall motion abnormalities without chronic 
changes in echocardiography,decision for cath lab should be promptly 
decided . 
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                                            SUMMARY 
 
Patient 
Characteristics 
New onset LBBB Old LBBB 
Age{>50} 73.9% 96.3% 
Sex[Male] 78.3% 62.96% 
Cardiac Risk 
Factors 
  
Hypertension 73.91% 77.77% 
Diabetes 69.56% 62.96% 
Hyperlipidemia 34.78% 37.03% 
Family History of 
CAD 
30.43% 37.03% 
Smoker 60.56% 62.96% 
Medical History   
H/O CAD 56.52% 62.96% 
PRIOR MI 21.73% 29.62% 
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PRIOR 
CABG/PTCA 
13% 14.81% 
TIMI 
SCORE 
0-1 30.43% 25.92% 
2-3 47.82% 51.85% 
>_4 21.73% 22.22% 
                           
 
73.9% of people with new LBBB are more than 50 years of age 
96.3% of people with old lbbb are more than 50 year of age.  Older age 
has higher history of old LBBB which shows as age progress incidence of 
lbbb is high 
             8.7% of the people with new LBBB were troponin positive while 
7.4% of the patient with old LBBB had Troponin positivity.Thus there is     
no Significant Difference in the incidence of  MI in  both new onset and 
Old LBBB in suspected Acute coronary syndrome. 
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CONCLUSION 
 
There is no difference in the incidence of Myocardial Infarction in 
the patients with old LBBB and new onset  LBBB. 
Hemodynamically stable Patients with suspected Acute Coronary  
Syndrome and new onset LBBB are not at increased risk of AMI. 
Presence  of LBBB whether new or old LBBB did not predict acute 
myocardial Infarction 
Algorithmic approach towards a suspected Acute coronary 
syndrome  should take into consideration hemodynamic status ,whether 
patient is in acute heart failure AND whether ECG fits into Smiths criteria 
and if any of them is present ,decision for reperfusion should be promptly 
taken. 
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PROFORMA 
Serial No.: 
Name: 
Age: 
Sex: 
Occupation: 
Address: 
 
IP. No.: 
D.O.A: 
D.O.D: 
Heart rate on admission: 
Systolic blood pressureon admission: 
ECG on admission:Old or new LBBB 
Prior MI: Yes/No  
Prior CAHD: Yes/No  
Prior CABG/PTCA: Yes/No  
102 
 
Famiy History of CAHD: Yes/No 
Smoking: Yes/No 
SHT: Yes/No 
DM: Yes/No 
Dyslipidemia: Yes/No 
Troponin T:Positive/Negative 
Echo for wall motion abnormalities:Present/Absent 
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MASTER CHART ABBREVIATIONS 
 
BP  – Blood pressure 
PR  -  Pulse rate 
Ecg  – Electrocardiogram 
LBBB – Left Bundle Branch Block 
Echo  - Echocardiogram 
DM  - Diabetes Mellitus 
CABG - Coronary Artery Bypass grafting 
MI  - Myocardial Infarction 
CAHD - Coronary Artery Heart Disease 
TIMI Score - Thrombolysis in Myocardial Infarction Score 
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CONSENT FORM 
 
 I am Dr .ASHOK S, carrying out a study on the topic “UTILITY OF 
LEFT BUNDLE BRANCH BLOCK AS THE DIAGNOSTIC 
CRITERION FOR MYOCARDIAL INFARCTION IN A 
HEMODYNAMICALLY STABLE PATIENT”.   
My research project is being carried out under the Department of  
General Medicine, Coimbatore Medical College and Hospital, Coimbatore. 
RESEARCH BEING DONE: 
“UTILITY OF LEFT BUNDLE BRANCH BLOCK AS 
THE DIAGNOSTIC CRITERION FOR MYOCARDIAL 
INFARCTION IN A HEMODYNAMICALLY STABLE 
PATIENT” 
SAMPLE SIZE:  
 50 patients. 
STUDY PARTICIPANTS: 
 Patients attending General Medicine Out Patient Department with the 
complaints of chest pain , Coimbatore Medical College and Hospital, 
Coimbatore. 
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LOCATION: 
Coimbatore Medical College and Hospital, Coimbatore. 
You, Shri./ Smt./ Kum. _________________________, aged ____ years, S/o / 
D/o / W/o _________________________, residing at ________________ 
_______________________________________ are requested to be a 
participant in the research study titled “UTILITY OF LEFT BUNDLE 
BRANCH BLOCK AS THE DIAGNOSTIC CRITERION FOR 
MYOCARDIAL INFARCTION IN A HEMODYNAMICALLY 
STABLE PATIENT” in Government Medical College Hospital, 
Coimbatore. You satisfy eligibility criteria as per the inclusion criteria. You can 
ask any question or seek any clarifications on the study that you may have 
before agreeing to participate. 
DECLINE FROM PARTICIPATION 
You are hereby made aware that participation in this study is purely 
voluntary and honorary and that you have the option and the right to decline 
from participation in the study. 
PRIVACY AND CONFIDENTIALITY 
You are hereby assured about your privacy.  Privacy of subject will be 
respected and any information about you or provided by you during the study 
will be kept strictly confidential. 
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AUTHORIZATION TO PUBLISH RESULTS   
Results of the study may be published for scientific purposes and/or 
presented to scientific groups, however you will not be identified; neither will 
your privacy be breached. 
 
STATEMENT OF CONSENT 
 
I, _____________________, do hereby volunteer and consent to 
participate in this study being conducted by Dr.ASHOKS .. I have read and 
understood the consent form / or it has been read and explained to me in my 
own language. The study has been fully explained to me, and I may ask 
questions at any time. 
 
Signature / Left Thumb Impression of the Volunteer Date:          Place: 
Signature and Name of witness     Date:          Place: 
Signature of the investigator: 
Name of the investigator:  
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xg;g[jy; gotk; 
 
bgah;  : 
ghypdk; : 
Kfthp :     taJ  : 
  
muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jt Jiwapy;  
gl;l nkw;gog;g[ gapYk; khzth; kU. R. mnrhf; mth;fs;  "nfhaKj;J}h; 
kUj;Jt fy;Y}hp kUj;Jtkidapy;   khuilg;ig  fz;L mwpjypy; 
,lJ fl;Lf;fpis  milg;gpd; gad;ghL" Ma;tpy; nkw;nfhs;Sk; 
bra;Kiw kw;Wk; midj;J tptu';fisa[k; nfl;Lf; bfhz;L vdJ 
re;njf';fis bjspt[gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. 
ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; fye;J 
bfhs;s rk;kjpf;fpnwd;. 
,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy;  
Ml;nrgid ,y;iy vd;gij bjhptpj;Jf;bfhs;fpnwd;. ve;j neuj;jpy; 
me;j Ma;tpypUe;J ehd; tpyfpf; bfhs;s vdf;F chpik cz;L 
vd;gija[k; mwpntd;.  
 
,lk; :                     ifbahg;gk; / nuif 
ehs; : 
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N a m e      A g e      S e x       B P        P R   T ro p  T       E C G     E ch o       D M P R IO R  C A B G /PT C AP rio r M I     C A H DV a lvu lar Sy stem ic H y pe rlip id em iaSm o k er
L B B B     H e art H y p erten sio n
D is eas e
M a r im u th u 58 M 12 O /8 0 7 4 N O ld 2 Y Y Y Y N Y Y Y
k aru pu sa m y 63 M 11 0 /82 7 8 N N ew 2 Y N N Y N Y Y Y
c hin am m a l 49 F 12 0 /70 8 8 N N ew 2 N Y Y Y N Y Y N
K a n n an 78 M 12 6 /84 8 6 N O ld 2 Y N N Y N Y N Y
isa k im u th u 48 M 11 0 /80 8 8 N O ld 2 Y N N N N Y Y Y
ra m a sa m y 90 M 11 6 /78 9 4 N O ld 2 Y N Y Y N N N N
S ek a r 38 M 13 8 /90 7 0 N N ew 2 N N N N Y Y N Y
C h a n dra n 57 M 12 0 /80 7 8 N N ew 2 N N Y N N N N Y
A la g a p p an 48 M 12 6 /84 6 8 P N ew 1 Y N N Y N Y N Y
k aliy a m m al 76 F 14 8 /94 8 2 N N ew 2 Y N N Y N Y N N
A s o k an 52 M 12 6 /76 8 4 N O ld 2 Y N N N Y Y Y Y
P er i ya n ay ag i 56 F 11 0 /70 9 8 P O ld 1 N Y Y Y N Y N N
G o v in d araj 64 M 12 8 /80 7 4 N O ld 2 N N N N N Y N Y
M ut h u 31 M 12 0 /80 7 8 N N ew 2 Y N N N N Y Y Y
k ala ia rasa n 66 M 13 8 /84 8 2 N O ld 2 N Y Y Y N Y N Y
S en t hil 54 M 12 0 /80 7 6 N O ld 2 Y N N Y N N N Y
R a d h a 60 F 14 0 /78 7 2 P O ld 2 Y N N N N Y N N
M an iva nn am 42 M 13 0 /86 7 8 N N ew 2 N N N N N Y N Y
G op i 65 M 12 0 /80 8 6 P N ew 1 Y Y Y N N Y Y N
D e v a raj 60 M 12 8 /88 8 2 N N ew 2 N N N N N N N Y
S ud a la iap pa n 53 M 13 0 /80 8 8 N O ld 2 Y N N N N Y N Y
R a m ath al 65 F 14 0 /90 9 0 N O ld 2 N N Y Y N Y Y N
S an m u g am 70 M 12 4 /86 7 4 P O ld 1 N N N Y Y Y Y Y
R a k a yi 85 F 12 0 /80 7 6 N O ld 2 Y N N Y N Y Y N
sa th y an 76 M 16 0 /90 8 4 N O ld 2 N N Y Y N Y N Y
v im a la 84 F 12 4 /78 8 8 N O ld 2 Y N N Y N Y N N
K a la iv an i 56 F 13 4 /88 8 2 N O ld 2 N N N N N Y Y Y
C h in a sam y 74 M 12 0 /80 9 0 N O ld 2 Y N Y Y N Y N N
ra ja s ek ar 66 M 10 0 /56 9 4 N N ew 2 Y N Y Y N Y Y Y
g irid h ara n 55 M 13 6 /70 7 6 N O ld 2 N N N N N Y N Y
K a n d an 65 M 13 4 /80 6 6 N O ld 2 Y N N N N Y N Y
v eer asa m y 54 M 13 8 /84 7 4 N O ld 2 N N N Y N Y Y Y
re kh a 26 F 13 4 /82 7 2 N N ew 2 N N N N Y N N N
ra m a n ad an 64 M 12 4 /84 7 8 N O ld 2 Y Y Y Y N N N Y
M A S T E R  C H A R T
 
109 
 
senathipadi 72 M 136/76 84 N New 2 Y N N Y N Y N Y
vinodini 53 F 126/84 88 N Old 2 N N N N N N N N
veerammal 61 F 110/66 90 P Old 2 Y N N Y N Y N N
arjunasamy 65 M 140/90 92 N New 2 N N N Y N Y N N
govindan 66 M 124/84 88 N New 2 Y N N Y N Y N Y
Murugan 72 M 128/76 70 N Old 2 Y N N Y N Y Y Y
kupanan 68 M 130/80 74 N New 2 Y N N Y N Y N Y
sabeena 56 F 122/86 78 N Old 2 Y N N N N N Y N
kataboman 54 F 136/84 80 N New 2 Y Y Y Y N Y N N
krishnammal 67 F 120/80 84 N New 2 Y N N N N Y Y N
kumaran 64 M 128/88 76 N New 2 Y N N Y N N Y Y
karupusamy 58 M 130/86 78 N New 2 Y N N Y N Y N Y
vedammal 67 F 128/86 74 N Old 1 Y N N Y N N N Y
visakan 75 M 120/86 78 N New 2 Y N N Y N Y Y Y
anandan 50 M 130/80 82 N New 2 Y N N N N N N Y
kumaraguru 65 M 110/66 76 N New 2 Y N N N N N N Y  
 
 
 
 
  
